[go: up one dir, main page]

WO2017218630A3 - Nanoparticules d'agent thérapeutique revêtues de phospholipide et procédés associés - Google Patents

Nanoparticules d'agent thérapeutique revêtues de phospholipide et procédés associés Download PDF

Info

Publication number
WO2017218630A3
WO2017218630A3 PCT/US2017/037402 US2017037402W WO2017218630A3 WO 2017218630 A3 WO2017218630 A3 WO 2017218630A3 US 2017037402 W US2017037402 W US 2017037402W WO 2017218630 A3 WO2017218630 A3 WO 2017218630A3
Authority
WO
WIPO (PCT)
Prior art keywords
phospholipid
therapeutic agent
related methods
agent nanoparticles
coated therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2017/037402
Other languages
English (en)
Other versions
WO2017218630A2 (fr
Inventor
Vuong Trieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autotelic LLC
Original Assignee
Autotelic LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autotelic LLC filed Critical Autotelic LLC
Publication of WO2017218630A2 publication Critical patent/WO2017218630A2/fr
Publication of WO2017218630A3 publication Critical patent/WO2017218630A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des nanoparticules revêtues de phospholipide contenant un agent thérapeutique, des compositions qui comprennent lesdites nanoparticules, ainsi que des procédés de production et d'utilisation desdites nanoparticules et compositions.
PCT/US2017/037402 2016-06-15 2017-06-14 Nanoparticules d'agent thérapeutique revêtues de phospholipide et procédés associés Ceased WO2017218630A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662350573P 2016-06-15 2016-06-15
US62/350,573 2016-06-15

Publications (2)

Publication Number Publication Date
WO2017218630A2 WO2017218630A2 (fr) 2017-12-21
WO2017218630A3 true WO2017218630A3 (fr) 2018-02-15

Family

ID=60663785

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/037402 Ceased WO2017218630A2 (fr) 2016-06-15 2017-06-14 Nanoparticules d'agent thérapeutique revêtues de phospholipide et procédés associés

Country Status (1)

Country Link
WO (1) WO2017218630A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US20080253960A1 (en) * 2004-04-01 2008-10-16 The Trustees Of The University Of Pennsylvania Center For Technology Transfer Lipoprotein-Based Nanoplatforms
US20100290983A1 (en) * 2009-05-15 2010-11-18 Baxter International Inc. Compositions and Methods for Drug Delivery
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres
US20150246137A1 (en) * 2012-09-27 2015-09-03 The University Of North Carolina At Chapel Hill Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US20080253960A1 (en) * 2004-04-01 2008-10-16 The Trustees Of The University Of Pennsylvania Center For Technology Transfer Lipoprotein-Based Nanoplatforms
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres
US20100290983A1 (en) * 2009-05-15 2010-11-18 Baxter International Inc. Compositions and Methods for Drug Delivery
US20150246137A1 (en) * 2012-09-27 2015-09-03 The University Of North Carolina At Chapel Hill Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof

Also Published As

Publication number Publication date
WO2017218630A2 (fr) 2017-12-21

Similar Documents

Publication Publication Date Title
WO2018109174A3 (fr) Anticorps anti-il-11
WO2018109170A3 (fr) Anticorps il-11ra
WO2018089261A3 (fr) Composés et méthodes de modulation de kinase de lymphocytes t inductible par l'interleukine 2
WO2015168019A3 (fr) Conjugués médicament-anticorps anti-ptk7
WO2018067512A8 (fr) Composés spirocycliques
GB201617000D0 (en) Metal-organic frameworks, methods for their manufacture and uses thereof
WO2015179658A3 (fr) Immunoconjugués et anticorps anti-gpc3
GB201712273D0 (en) The P.I.R. Co. Ltd - business model
IL272055A (en) 8,1-naphthyridinone compounds and their uses
WO2015191945A3 (fr) Formes solides de sofosbuvir
SG11201908281VA (en) Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof
WO2020127145A3 (fr) Matériaux de dispositifs électroniques
HK1252614A1 (zh) 二环化合物
EP3312199A4 (fr) Modificateur à base d'azasilane et procédé de préparation d'un polymère à base de diène conjugué modifié à l'aide de celui-ci
WO2015128858A8 (fr) Formulation enrichie de plasma
EP3505166A4 (fr) Matériau antibactérien en trois dimensions, procédé de sa production (et variantes) et installation pour la mise en oeuvre du procédé
WO2017218630A3 (fr) Nanoparticules d'agent thérapeutique revêtues de phospholipide et procédés associés
WO2015170331A3 (fr) Nanomatériaux inorganiques
EP3713465A4 (fr) Socle multifonction
WO2017059401A3 (fr) Ligands du récepteur des androgènes
PL3105243T3 (pl) Pochodne 2',3'-dideoksy-5-fluorourydyny, sposób ich wytwarzania i zastosowanie
WO2017011637A3 (fr) Éléments d'interconnexion mécaniquement flexibles, leurs procédés de fabrication et procédés d'utilisation
HK40099430A (zh) 递送装置及其制造方法
WO2015196144A3 (fr) Antagonistes du récepteur des androgènes
HK40103775A (en) Anti-hla-dq2.5 antibody

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17813994

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17813994

Country of ref document: EP

Kind code of ref document: A2